» Articles » PMID: 11861881

Natural Selection on the Erythrocyte Surface

Overview
Journal Mol Biol Evol
Specialty Biology
Date 2002 Feb 28
PMID 11861881
Citations 54
Authors
Affiliations
Soon will be listed here.
Abstract

Surface glycoproteins are principal receptors used by pathogens to invade target cells. It has been suggested that mammalian erythrocyte surface glycoproteins function as decoy receptors attracting pathogens to the anucleated erythrocyte and away from their target tissues. Glycophorin A (GYPA) is solely expressed on the erythrocyte surface where it is the most abundant sialoglycoprotein, although its function is unknown. The pathogen decoy hypothesis may be relevant here, as GYPA has been shown in vitro to bind numerous viruses and bacteria, which do not infect erythrocytes. However, it is also a receptor for erythrocyte invasion by the malarial parasite Plasmodium falciparum. Analyses of gypa sequence variation among six higher primates and within a human population show that there is a large excess of replacement (nonsynonymous) substitutions along each primate lineage (particularly on exons 2-4 encoding the extracellular glycosylated domain of GYPA) and a significant excess of polymorphisms in exon 2 (encoding the terminal portion of the extracellular domain) within humans. These two signatures suggest that there has been exceptionally strong positive selection on this receptor driving GYPA divergence during primate evolution and balancing selection maintaining allelic variation within human populations. The pathogen decoy hypothesis alone is adequate to explain both these signatures of between-species and within-species diversifying selection. This has implications for understanding the functions of erythrocyte surface components and their roles in health and disease.

Citing Articles

Single-cell multi-omics reveal stage of differentiation and trajectory-dependent immunity-related gene expression patterns in human erythroid cells.

Perik-Zavodskii R, Perik-Zavodskaia O, Alrhmoun S, Volynets M, Shevchenko J, Nazarov K Front Immunol. 2024; 15:1431303.

PMID: 39267736 PMC: 11390661. DOI: 10.3389/fimmu.2024.1431303.


Back to the Basics of SARS-CoV-2 Biochemistry: Microvascular Occlusive Glycan Bindings Govern Its Morbidities and Inform Therapeutic Responses.

Scheim D, Parry P, Rabbolini D, Aldous C, Yagisawa M, Clancy R Viruses. 2024; 16(4).

PMID: 38675987 PMC: 11054389. DOI: 10.3390/v16040647.


Exploring unconventional attributes of red blood cells and their potential applications in biomedicine.

Anastasiadi A, Arvaniti V, Hudson K, Kriebardis A, Stathopoulos C, DAlessandro A Protein Cell. 2024; 15(5):315-330.

PMID: 38270470 PMC: 11074998. DOI: 10.1093/procel/pwae001.


Sialylated Glycan Bindings from SARS-CoV-2 Spike Protein to Blood and Endothelial Cells Govern the Severe Morbidities of COVID-19.

Scheim D, Vottero P, Santin A, Hirsh A Int J Mol Sci. 2023; 24(23).

PMID: 38069362 PMC: 10871123. DOI: 10.3390/ijms242317039.


Perspective on the Application of Erythrocyte Liposome-Based Drug Delivery for Infectious Diseases.

Krivic H, Himbert S, Rheinstadter M Membranes (Basel). 2022; 12(12).

PMID: 36557133 PMC: 9785899. DOI: 10.3390/membranes12121226.